Atlasclear Holdings, Inc. current report, 17 April 2024

AtlasClear Holdings, Inc. — Form 8-K Summary

Business Context and Reporting Period

AtlasClear Holdings, Inc. filed a Current Report on Form 8-K dated April 17, 2024. The filing reports developments related to financing obligations arising from the Company’s business combination and related securities issuance. The Company’s common stock trades on the NYSE American under the symbol ATCH.

Key Financial and Capital Structure Information

  • Chardan Note: On February 9, 2024, the Company and Chardan Capital Markets, LLC entered into a convertible promissory note with aggregate principal of $4.15 million. The note settled Chardan’s fee relating to Quantum FinTech Acquisition Corporation’s business combination marketing agreement.
  • Seller Notes: The Company issued convertible promissory notes to the sellers of Wilson-Davis & Co. Inc. in connection with the business combination.
  • Interest payment: The Company directed Continental to issue 145,210 shares of common stock to the Sellers for the first quarterly interest payments on the Seller Notes.
  • The filing does not provide revenue, profit, cash flow, margin, debt-balance, or liquidity metrics beyond the stated $4.15 million Chardan Note principal.

Material Changes and Unusual Items

  • Quantum Ventures LLC, Quantum’s primary sponsor, filed a statement of claim with FINRA Dispute Resolution Services against Chardan on March 22, 2024.
  • Because of the pending arbitration, the Company will not register the unregistered common shares issuable under the Chardan Note on any Form S-1 resale registration statement it files with the SEC until the matter is resolved.
  • The issuance of 145,210 shares to the Seller Note holders represents payment of the first quarterly interest obligation in equity rather than cash, based on the filing’s description.

Guidance, Outlook, Risks, and Contingencies

The filing provides no financial guidance or operating outlook. The pending FINRA arbitration may affect the timing or availability of resale registration for shares issuable under the Chardan Note. The filing does not state the likely outcome, financial exposure, or expected resolution date of the arbitration.

Investor Verification Items

  • Verify the terms, conversion provisions, maturity, interest rate, and outstanding balance of the Chardan Note.
  • Assess how the FINRA arbitration could affect the Company, Chardan, Quantum Ventures LLC, and the resale registration of related shares.
  • Confirm the terms and share-count calculation for the 145,210 shares issued as Seller Note interest.
  • Review subsequent filings for additional equity issuance, dilution, registration statements, or changes to the arbitration status.
  • Reconcile these capital structure events with the Company’s latest audited financial statements and liquidity disclosures.